Literature DB >> 8456856

Visceral anomalies in the Apert syndrome.

M M Cohen1, S Kreiborg.   

Abstract

We report on visceral anomalies found in 136 patients with Apert syndrome. Autopsies were only performed on 12 of these cases. Thus, the percentage of anomalies found in our patients should be considered a minimum estimate because of the possibility of clinically silent visceral anomalies, minor internal anomalies, and anatomic variations. Cardiovascular and genitourinary anomalies were found most commonly, occurring in 10% and 9.6%, respectively. As expected, complex and multiple cardiac anomalies were frequently associated with early death. Among genitourinary anomalies, hydronephrosis (3%) and cryptorchidism (4.5%, n = 66 males) occurred most commonly. In contrast, anomalies of the respiratory system (1.5%) and gastrointestinal anomalies (1.5%) occurred with lower frequency. The finding of a solid cartilaginous trachea is particularly important because no case was diagnosed during life but rather, only at autopsy. Because cardiovascular and genitourinary anomalies occur with significant frequency, they should be considered in the workup of all Apert newborn infants. We also recommend MRI study of the trachea in any infant with signs and symptoms of lower respiratory compromise.

Entities:  

Mesh:

Year:  1993        PMID: 8456856     DOI: 10.1002/ajmg.1320450618

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  28 in total

1.  A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes.

Authors:  M K Hajihosseini; S Wilson; L De Moerlooze; C Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development.

Authors:  Takamitsu Maruyama; Anthony J Mirando; Chu-Xia Deng; Wei Hsu
Journal:  Sci Signal       Date:  2010-05-25       Impact factor: 8.192

3.  3-Dimensional morphometric analysis of murine bladder development and dysmorphogenesis.

Authors:  Ashley Carpenter; Andrew Paulus; Melissa Robinson; Carlton M Bates; Michael L Robinson; David Hains; David Kline; Kirk M McHugh
Journal:  Dev Dyn       Date:  2012-01-31       Impact factor: 3.780

4.  Role of fibroblast growth factor receptor 2 in kidney mesenchyme.

Authors:  David Hains; Sunder Sims-Lucas; Kayle Kish; Monalee Saha; Kirk McHugh; Carlton M Bates
Journal:  Pediatr Res       Date:  2008-12       Impact factor: 3.756

Review 5.  Role of fibroblast growth factor receptor signaling in kidney development.

Authors:  Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2011-01-11       Impact factor: 3.714

6.  Comparison of ultrasound and magnetic resonance imaging in the prenatal diagnosis of Apert syndrome: report of a case.

Authors:  A Giancotti; V D'Ambrosio; A De Filippis; C Aliberti; G Pasquali; S Bernardo; L Manganaro
Journal:  Childs Nerv Syst       Date:  2014-02-25       Impact factor: 1.475

Review 7.  The molecular and cellular basis of Apert syndrome.

Authors:  Chao Liu; Yazhou Cui; Jing Luan; Xiaoyan Zhou; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2013-11

Review 8.  Impact of genetics on the diagnosis and clinical management of syndromic craniosynostoses.

Authors:  Nneamaka B Agochukwu; Benjamin D Solomon; Maximilian Muenke
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

Review 9.  Fibroblast growth factor receptor signaling in kidney and lower urinary tract development.

Authors:  Kenneth A Walker; Sunder Sims-Lucas; Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2015-08-21       Impact factor: 3.714

Review 10.  Role of fibroblast growth factor receptor signaling in kidney development.

Authors:  Carlton M Bates
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.